
|Articles|July 26, 2022
Sanofi Partners With Howard University
Advertisement
Sanofi has announced a collaboration with Howard University College of Pharmacy for a two-year post-professional Doctorate in Pharmacy fellowship program.
Set to begin in the second half of 2022, the program will award ten PharmD graduate students an opportunity to participate in practical learning experiences across multiple research and development fields, including oncology, rare diseases, neurology, immunology, regulatory, pharmacovigilance, clinical and operations, as well as US medical, public policy, and patient advocacy.
Read more about the collaboration
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Patient Centricity: What Rare Disease Research Gets Right
2
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
3
ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD
4
The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness
5




